pansatori continues on its growth path:

Braunau am Inn, Austria, March 18, 2025. Rethinking Tinnitus Treatment: Following successful market entries in Lithuania, Greece, the Netherlands, Belgium, and Luxembourg, contracts are now close to being signed in the United Kingdom and Ireland. In response to growing demand, Pansatori is now expanding into additional European markets — with a particular focus on France, Spain, Germany, Portugal, and Italy.

Tinnitus affects millions of people worldwide and represents a significant burden for those living with it. With ForgTin®, an innovative and multi-award-winning therapy, Pansatori offers an effective solution that has already established a strong presence in several European markets. The company is now continuing its targeted expansion, entering new regions with high market potential.

Innovative technology meets scientific knowledge

Tinnitus is caused by faulty signal processing in the brain. While traditional treatments often only alleviate the symptoms, ForgTin® addresses the root cause by using gentle stimulation of specific areas around the ear.

• Musculus Auricularis Superior – a muscle that moves the auricle and is connected to the central nervous system.
• Musculus Auricularis Posterior – a muscle that plays a role in the perception of vibrations and sends sensory impulses to the brain.
• Impulse area of the parasympathetic nervous system – an important part of the autonomic nervous system responsible for relaxation and the regulation of stress responses.

Through targeted impulses, missignals in the nerve pathways of the musculoskeletal system are modulated and transmitted to the brainstem. This can sustainably reduce the perception of tinnitus or even make it "forgotten" entirely – hence the name ForgTin® ("forget tinnitus").

The technology was developed in close collaboration with experts from medicine, neuroscience, and medical technology. It is based on the latest findings in neuroplasticity research, which show that the brain can actively reorganize itself when targeted sensory stimuli are applied. ForgTin® leverages these mechanisms to correct the misprocessing of tinnitus signals – a completely new approach to tinnitus treatment.

Recent research confirms that this method is effective: 85% of users report a significant improvement in at least one symptom within six weeks. These improvements range from a reduction in perceived volume to a noticeable improvement in sleep quality and concentration.

Expansion due to rising demand

Pansatori's international expansion is significantly driven by growing demand from various countries. Pharmacists and ENT specialists, in particular, report that patients are actively seeking ForgTin®. As a result, distributors with strong sales networks are proactively approaching Pansatori to establish partnerships and introduce the product into new markets.

Another milestone in the expansion is the linguistic adaptation of the therapy for international markets: The ForgTin® app is already available in French, with a Spanish version following shortly. This makes it easier for patients to access the therapy and enables broader usage in new markets.

A trusted, simple-to-use tinnitus treatment

ForgTin® is an approved medical device designed to be worn during the day. After just 15 minutes of use, it becomes unnoticeable – exactly as it should. Without the need for medication, invasive procedures, or complicated handling, ForgTin® offers a simple, safe, and reliable solution for people with tinnitus.

"Our goal is to establish ForgTin® as the standard therapy for tinnitus worldwide. We want to provide patients with a real, non-invasive alternative – without medication or complicated treatments," says Mag. Klaus Grübl, CEO of Pansatori. As a former tinnitus sufferer, he knows the challenges of the condition from personal experience and is passionately committed to providing a sustainable solution.

Pansatori meets LUNOVA – Partner for the Benelux countries

These countries offer significant market potential, as the demand for effective tinnitus therapies is particularly high. Pansatori is focusing on long-term partnerships with distributors, specialty retailers, audiologists, and MedTech companies that wish to establish ForgTin® in their respective markets.

Pansatori meets LUNOVA – Partner for the Benelux countries

These countries offer significant market potential, as the demand for effective tinnitus therapies is particularly high. Pansatori is focusing on long-term partnerships with distributors, specialty retailers, audiologists, and MedTech companies that wish to establish ForgTin® in their respective markets.

With its innovative, non-invasive technology and impressive treatment results, ForgTin® is setting new standards in tinnitus therapy – thus accelerating Pansatori's international expansion.